| Size | 100 mL/500 mL |
| Advantages | Ovarian cancer organoids precisely replicate the tumor's microenvironment, enabling observation of cell growth dynamics. This system allows for the tracking of tumor cell changes during drug treatment and facilitates the screening of drug efficacy and toxicity. |
| Species | Human |
| Components | Basal Medium A; Culture Supplement B, C & D. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Basal Medium A: 4°C, 1 year; Culture Supplement B, C & D: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Culture Supplement B, C & D: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.